Discusses Accelerated FDA Approval of TRUTAKNA for IgA Nephropathy July 7, 2026 4:30 PM EDTCompany ParticipantsSean Grant ...
First in a three-part series. This story was produced with support from the Pulitzer Center. In the past four springs, state employees in small planes and a helicopter have combed the skies of ...
Natural Gas Industry Decision-Makers Gather at this Annual Forum to Consider Insights into U.S. Rockies and West Natural Gas ...
TRUTAKNA is the first and only available therapy that binds both B-cell activating factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), ...
Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Morning Overview on MSN
Ozempic helped adults over 65 shed more than 15% of their body weight in a new study
Adults aged 65 and older who took semaglutide 2.4 mg lost an average of 15.4% of their body weight over 68 weeks, according ...
Trust Stamp (Nasdaq: IDAI), today announced that its Maltese subsidiary, Trust Stamp Malta Limited, has been selected as a ...
Leaders from industry, government and higher education from across the state gathered in June at the CSCMP Supply Chain Hall of Fame, an event that brought together experts in supply chain, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results